You are here: Home » News » Breakthrough

Vargas Pharmaceutical S.A.  company has already been entering upon 3rd phase of clinical trial of a new drug for the treatment of Alzheimer disease. We believe in successful end of the study and ensuing registration of the new drug which allows improving patienthood significantly.